Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Noncarboplatin-induced Sensorineural Hearing Loss in a Patient With an Intracranial Nongerminomatous Germ Cell Tumor.

Vitanza NA, Shaw TM, Gardner SL, Allen JC, Harter DH, Karajannis MA.

J Pediatr Hematol Oncol. 2016 May;38(4):312-6. doi: 10.1097/MPH.0b013e318287310e.

PMID:
23652864
2.

Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.

Bertolini P, Lassalle M, Mercier G, Raquin MA, Izzi G, Corradini N, Hartmann O.

J Pediatr Hematol Oncol. 2004 Oct;26(10):649-55.

PMID:
15454836
3.

Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.

Chen WC, Jackson A, Budnick AS, Pfister DG, Kraus DH, Hunt MA, Stambuk H, Levegrun S, Wolden SL.

Cancer. 2006 Feb 15;106(4):820-9.

4.

Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.

Freilich RJ, Kraus DH, Budnick AS, Bayer LA, Finlay JL.

Med Pediatr Oncol. 1996 Feb;26(2):95-100.

PMID:
8531860
5.

[Combined therapy of intracranial germ cell tumors in children].

Sachivko NV, Artiushkevich LV.

Vopr Onkol. 1997;43(4):469-72. Russian.

PMID:
9381709
6.

The incidence of hearing impairment after successful treatment of neuroblastoma.

Simon T, Hero B, Dupuis W, Selle B, Berthold F.

Klin Padiatr. 2002 Jul-Aug;214(4):149-52.

PMID:
12165893
7.
8.

[The ototoxicity of the cytostatic drug carboplatin in patients with head-neck tumors].

Bauer FP, Westhofen M, Kehrl W.

Laryngorhinootologie. 1992 Aug;71(8):412-5. German.

PMID:
1388466
9.

Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.

Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC.

Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):779-88. doi: 10.1016/j.ijrobp.2008.05.040. Epub 2008 Aug 15.

PMID:
18707819
10.

Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.

Peleva E, Emami N, Alzahrani M, Bezdjian A, Gurberg J, Carret AS, Daniel SJ.

Pediatr Blood Cancer. 2014 Nov;61(11):2012-7. doi: 10.1002/pbc.25123. Epub 2014 Jun 29.

PMID:
24976616
11.

Stereotactic radiotherapy for pediatric intracranial germ cell tumors.

Zissiadis Y, Dutton S, Kieran M, Goumnerova L, Scott RM, Kooy HM, Tarbell NJ.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):108-12.

PMID:
11516859
12.

Ototoxicity after combined platinum and fractionated radiation in a novel guinea pig model.

Miller MW, Riedel G, Hoistad D, Sutherland C, Juhn SK, Adams GL, Griffin R, Ondrey FG.

Am J Otolaryngol. 2009 Jan-Feb;30(1):1-7. doi: 10.1016/j.amjoto.2007.12.003. Epub 2008 Jun 20.

PMID:
19027506
13.

[Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].

BirĂ³ K.

Magy Onkol. 2009 Sep;53(3):279-83. doi: 10.1556/MOnkol.53.2009.3.8. Hungarian.

14.

Delayed surgical resection of central nervous system germ cell tumors.

Weiner HL, Lichtenbaum RA, Wisoff JH, Snow RB, Souweidane MM, Bruce JN, Finlay JL.

Neurosurgery. 2002 Apr;50(4):727-33; discussion 733-4.

PMID:
11904022
15.

Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma.

Parsons SK, Neault MW, Lehmann LE, Brennan LL, Eickhoff CE, Kretschmar CS, Diller LR.

Bone Marrow Transplant. 1998 Oct;22(7):669-74.

16.

Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.

Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D.

Ear Hear. 2008 Dec;29(6):875-93. doi: 10.1097/AUD.0b013e318181ad99.

PMID:
18753950
17.

Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors: a multiinstitutional retrospective analysis of 41 patients.

Ogawa K, Toita T, Nakamura K, Uno T, Onishi H, Itami J, Shikama N, Saeki N, Yoshii Y, Murayama S.

Cancer. 2003 Jul 15;98(2):369-76.

18.
19.

The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.

Dahlborg SA, Petrillo A, Crossen JR, Roman-Goldstein S, Doolittle ND, Fuller KH, Neuwelt EA.

Cancer J Sci Am. 1998 Mar-Apr;4(2):110-24.

PMID:
9532413
20.

Clinical study of intracranial nongerminomatous germ cell tumors producing alpha-fetoprotein.

Itoyama Y, Kochi M, Yamamoto H, Kuratsu J, Uemura S, Ushio Y.

Neurosurgery. 1990 Sep;27(3):454-60.

PMID:
1700327

Supplemental Content

Support Center